Designated by the Canadian government in July 2010 as an entity contributing to Iran's proliferation-sensitive nuclear activities or to its development of chemical, biological or nuclear weapons or their delivery systems; designation prohibits Canadian parties from providing goods or financial services to the entity or dealing in property held by the entity; an affiliate of Tamin Pharmaceutical Investment Co.; produces pharmaceutical products; formerly known as Iran Pharmaceutical Development and Investment Company; established in 1983.